FEBS Letters · 2003 · 28 citations · 39 references
Life SciencesMolecular BiologyPharmacologyApoptosisProtein-protein InteractionsTranscriptional RegulationApoptosis ModulationApoptosis PharmacologyApoptosis RegulationHepatic PathophysiologyNuclear Receptor SignalingViral HepatitisGrowth Inhibition AssaysHepatitis B Virus-associated CarcinogenesisHepatocellular Carcinoma PathogenesisPeroxisome Proliferator-activated Receptor Gamma AgonismTherapeutic Growth Inhibition
Ligand activation of peroxisome proliferator-activated receptor gamma (PPARgamma) has been reported to induce growth inhibition and apoptosis in various cancers including hepatocellular carcinoma (HCC). However, the effect of hepatitis B virus X protein (HBx) on PPARgamma activation has not been characterized in hepatitis B virus (HBV)-associated HCC. Herein, we demonstrated that HBx counteracted growth inhibition caused by PPARgamma ligand in HBx-associated HCC cells. We found that HBx bound to DNA binding domain of PPARgamma and HBx/PPARgamma interaction blocked nuclear localization and binding to recognition site of PPARgamma. HBx significantly suppressed a PPARgamma-mediated transactivation. These results suggest that HBx modulates PPARgamma function through protein-protein interaction.
39
HBx gene of hepatitis B virus induces liver cancer in transgenic mice
Chang‐Min Kim, K. Koike, Izumu Saito et al. · Nature · 1991 · 1.2K citations
Differentiation and reversal of malignant changes in colon cancer through PPARγ
Pasha Sarraf, Elisabetta Mueller, Daniel M. Jones et al. · Nature Medicine · 1998 · 973 citations